XML 35 R25.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation and Equity Grants (Tables)
3 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Stock-based compensation expense shown in the table below is recorded in general and administrative expenses in our consolidated statements of operations as follows (in thousands):

Three Months Ended
December 31,
20252024
DLH employees (a)$550 $13 
Non-employee directors (b)97 180 
Total stock compensation expense
$647 $193 

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, and stock option grants to employees during prior fiscal years. The RSUs issued and outstanding totaled 959,582 and 708,325 shares at December 31, 2025 and 2024, respectively. During the three months ended December 31, 2025 and 2024, the Company granted 427,046 and 312,906 shares of restricted stock units, respectively. During the three months ended December 31, 2025, 380,338 shares of the RSUs granted have performance-based vesting criteria and the remaining 46,708 shares have service-based vesting criteria. During the three months ended December 31, 2024, 156,453 shares of the RSUs granted have performance-based vesting criteria and the remaining 156,453 shares have service-based vesting criteria.
Unrecognized stock-based compensation expense is presented in the table below (in thousands):

December 31,
 20252024
Unrecognized expense for DLH employees (a)
3,783 5,302 
Unrecognized expense for non-employee directors
290 539 
Total unrecognized expense
$4,073 $5,841 

(a) On a weighted average basis, the unrecognized expense as of December 31, 2025 is expected to be recognized within the next 2.84 years.
Summary of Performance Vesting Criteria and Restricted Stock Unit Activity
Volatility
50%
Grant DatePerformance Vesting BasePerformance Vesting Criteria(Years)Fair Value
December 17, 2025RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20283$1.38 
December 17, 2025Stock price
Stock price is at least $12.62 per share average for the 30 days prior to the end of the performance period
3$1.74 
December 20, 2024RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20273$0.65 
December 20, 2024Stock price
Stock price is at least $23.04 per share average for the 30 days prior to the end of the performance period
3$1.67 
Notes:
Results based on 100,000 simulations
Restricted stock unit activity for the three months ended December 31, 2025

  Performance Vesting
Service
Vesting
Total
Outstanding, September 30, 2025
232,461 232,460 464,921 
Granted
380,338 114,323 494,661 
Vested
— — — 
Cancelled— — — 
Outstanding, December 31, 2025
612,799 346,783 959,582 
Schedule of Stock Option Activity A summary of the Company's stock option awards is as follows:
(in years)
Weighted
WeightedAverage(in thousands)
(in thousands)AverageRemainingAggregate
Number ofExerciseContractualIntrinsic
SharesPriceTermValue
Options outstanding, September 30, 2025
937 $9.65 5.4$10 
Granted250 — — — 
Exercised
— — — — 
Cancelled— — — — 
Options outstanding, December 31, 2025
1,187 $8.85 6.30$10 
Vested and exercisable, December 31, 2025
902 $9.59 5.30$10 
Schedule of Option Shares Outstanding, Vested and Expected to Vest
Stock option shares outstanding, vested and unvested balance as follows (in thousands):
December 31,September 30,
20252025
Vested and exercisable902 902 
Unvested (a)285 35 
Options outstanding1,187 937 
(a) Certain awards vest upon satisfaction of certain performance criteria.